Document Detail


Histological characteristics of breast carcinoma in blacks and whites.
MedLine Citation:
PMID:  7519506     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tumor characteristics of 963 newly diagnosed invasive breast cancer cases from the population-based Black/White Cancer Survival Study were evaluated. Representative slides of the tumors were requested from all participating hospitals of three metropolitan areas and reviewed by one expert pathologist, blinded in regard to the age and race of patients. Nine tumor characteristics were evaluated for black and white patients. After adjusting for age, stage, and metropolitan area, blacks were significantly more likely to have high grade nuclear atypia [odds ratio (OR) = 1.97, 95% confidence interval (CI) = 1.27-3.04]; high mitotic activity (OR = 2.05, 95% CI = 1.34-3.14), grade 3 tumors (OR = 1.58, 95% CI = 1.02-2.45), and more necrosis (OR = 1.51, 95% CI = 1.16-1.98); and less likely to have well defined tubular formation (OR = 0.57, 95% CI = 0.42-0.77), marked fibrosis (OR = 0.65, 95% CI = 0.45-0.94), and positive estrogen receptor status (OR = 0.78, 95% CI = 0.58-1.05). These black/white differences remained after controlling for socioeconomic status (SES), body mass index, use of alcohol and tobacco, reproductive experience, and health care access and utilization. No significant racial differences were found for blood vessel invasion and lymphatic invasion. Although white women of high SES had more favorable tumors than those of low SES, the same pattern was not observed for blacks. High SES black women had statistically nonsignificant elevated ORs of a high mitotic index and tumor grade. These racial differences in tumor biology may have etiological and clinical implications.
Authors:
V W Chen; P Correa; R J Kurman; X C Wu; J W Eley; D Austin; H Muss; C P Hunter; C Redmond; M Sobhan
Related Documents :
9426716 - Grading of upper urinary tract transitional cell carcinoma by computed dna content and ...
7508886 - Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocar...
10667156 - P53 immunohistochemistry for distinguishing reactive mesothelium from low grade ovarian...
6199966 - Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prost...
18539036 - Synthesis and evaluation of unsymmetrical polyamine derivatives as antitumor agents.
21961496 - Vb-111 for cancer.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology     Volume:  3     ISSN:  1055-9965     ISO Abbreviation:  Cancer Epidemiol. Biomarkers Prev.     Publication Date:  1994 Mar 
Date Detail:
Created Date:  1994-09-08     Completed Date:  1994-09-08     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9200608     Medline TA:  Cancer Epidemiol Biomarkers Prev     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  127-35     Citation Subset:  IM    
Affiliation:
Department of Pathology, Louisiana State University Medical Center, New Orleans 70112-1393.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
African Continental Ancestry Group*
Aged
Breast / pathology
Breast Neoplasms / etiology,  mortality,  pathology*
Confidence Intervals
European Continental Ancestry Group*
Female
Humans
Lymphatic Metastasis
Microtubules / ultrastructure
Middle Aged
Mitotic Index
Necrosis
Neoplasm Staging
Neoplasms, Hormone-Dependent / etiology,  mortality,  pathology
Neovascularization, Pathologic / pathology
Odds Ratio
Receptors, Estrogen / analysis
Risk Factors
Socioeconomic Factors
Survival Rate
United States / epidemiology
Urban Population* / statistics & numerical data
Grant Support
ID/Acronym/Agency:
N01-CN-45174/CN/NCI NIH HHS; N01-CN-45175/CN/NCI NIH HHS; N01-CN-45176/CN/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Receptors, Estrogen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatitis markers in Malaysians with hepatocellular carcinoma.
Next Document:  The expression of FMS, KIT and FLT3 in hematopoietic malignancies.